📊 CNXC Key Takeaways
Investment Thesis
Concentrix faces severe profitability challenges with negative operating (-9.3%) and net margins (-13.0%), generating a $1.3B net loss despite $9.8B in revenue. While operating cash flow remains positive at $807M and liquidity is adequate, the company's inability to convert revenue to profit, combined with high leverage (1.67x debt-to-equity) and significant insider activity, indicates structural operational problems requiring urgent turnaround actions.
CNXC Strengths
- Positive free cash flow generation of $572.5M provides financial flexibility
- Adequate liquidity with 1.40x current and quick ratios supporting near-term obligations
- Healthy gross margin of 35% demonstrates pricing power at the production level
- Stable revenue base of $9.8B with modest growth suggesting market demand presence
CNXC Risks
- Severe operating loss of -$918.2M and net loss of -$1.3B indicating unsustainable cost structure
- Negative ROE (-46.6%) and ROA (-11.9%) demonstrate poor capital allocation and asset utilization
- High leverage ratio of 1.67x with $4.6B long-term debt limits financial flexibility during distress
- Unable to calculate interest coverage ratio, suggesting potential debt servicing concerns
- Deteriorating EPS performance (-648.8% YoY) signals worsening shareholder value destruction
Key Metrics to Watch
- Operating margin recovery trajectory and path to positive EBIT
- Debt reduction progress and debt-to-equity ratio improvement
- Net income return to profitability and net margin expansion
- Operating cash flow sustainability and FCF generation consistency
- Insider transaction patterns indicating management confidence in turnaround
CNXC Financial Metrics
💡 AI Analyst Insight
Concentrix Corp presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
CNXC Profitability Ratios
CNXC vs Default Sector
How Concentrix Corp compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CNXC Balance Sheet & Liquidity
CNXC 5-Year Financial Trend
5-Year Trend Summary: Concentrix Corp's revenue has grown significantly by 76% over the 5-year period, indicating strong business expansion. The most recent EPS of $5.70 reflects profitable operations.
CNXC Growth Metrics (YoY)
CNXC Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $2.4B | $16.6M | $0.25 |
| Q2 2025 | $2.4B | $42.1M | $0.63 |
| Q1 2025 | $2.4B | $52.1M | $0.76 |
| Q3 2024 | $1.6B | $16.6M | $0.25 |
| Q2 2024 | $1.6B | $66.8M | $0.98 |
| Q1 2024 | $1.6B | $52.1M | $0.76 |
| Q3 2023 | $1.6B | $77.6M | $1.49 |
| Q2 2023 | $1.6B | $78.9M | $1.51 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CNXC Capital Allocation
CNXC SEC Filings
Access official SEC EDGAR filings for Concentrix Corp (CIK: 0001803599)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CNXC
What is the AI rating for CNXC?
Concentrix Corp (CNXC) has an AI rating of SELL with 85% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CNXC's key strengths?
Positive free cash flow generation of $572.5M provides financial flexibility. Adequate liquidity with 1.40x current and quick ratios supporting near-term obligations.
What are the risks of investing in CNXC?
Severe operating loss of -$918.2M and net loss of -$1.3B indicating unsustainable cost structure. Negative ROE (-46.6%) and ROA (-11.9%) demonstrate poor capital allocation and asset utilization.
What is CNXC's revenue and growth?
Concentrix Corp reported revenue of $9.8B.
Does CNXC pay dividends?
Concentrix Corp pays dividends, with $89.6M distributed to shareholders in the trailing twelve months.
Where can I find CNXC SEC filings?
Official SEC filings for Concentrix Corp (CIK: 0001803599) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CNXC's EPS?
Concentrix Corp has a diluted EPS of $-20.36.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.